**5. Conclusions**

EBRT reduces the risk of loco-regional recurrence in locally advanced DTC. EBRT is indicated in gross loco-regional residual disease after surgery, extra-thyroidal extension with radioiodine non avid microscopic residual disease, inoperable locoregional recurrence which fails to concentrate iodine; and in the palliation of metastatic disease.
